US Senate panel unanimously backs nomination of Robert Califf as FDA head

13 January 2016

The US Senate's Health, Education, Labor and Pensions Committee unanimously voted in favour of approval of Robert Califf as Commissioner of the Food and Drug Administration (FDA).

In March, Mr Califf was nominated for the post by President Barack Obama following the resignation of former Commissioner Margaret Hamburg. Mr Califf is due to face a vote by the full Senate for final appointment.

Chairman Senator Lamar Alexander said: “The FDA affects every single American almost every single day. It’s vital that we have the right person leading that agency and that it have a confirmed leader.”

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK